MIAMI, Jan. 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 78th Emerging Growth Conference on January 15 & 16, 2025.
The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.
Register for the Conference here.
Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.
For updates, follow us on Twitter
Day 1 - Today
January 15, 2025
9:00
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.
9:35
Introduction
9:40 – 10:10
Brazil Potash (NYSE American: GRO)
Keynote speaker: Matt Simpson, CEO & Mayo Schmidt, Executive Chairman
10:15 – 10:45
XBP Europe Holdings, Inc. (NASDAQ: XBP)
Keynote speaker: Andrej Jonovic, CEO & Director
11:25 - 11:55
MarketWise , Inc. (NASDAQ: MKTW)
Keynote speaker: Erik Mickels, CFO
1:10 – 1:40
Alt Equity – A private company
Keynote speaker: Daniel Wait, President / Founder
1:45 – 2:15
Regen BioPharma Inc. (OTC Pink: RGBP)
Keynote speakers: David Koos, President / CEO, and Harry M. Lander, Ph.D. Senior Scientific Consultant
2:20 – 2:50
Cannabis Bioscience International Holdings Inc. (OTC Pink: CBIH)
Keynote speakers: Dante Picaso, President / CEO
2:55 – 3:05
The Birch Co. (OTC Pink: ATWT)
Keynote speaker: Angus Martin, President & CEO
3:10 – 3:20
U Power Limited (NASDAQ: UCAR)
Keynote speaker: Paul Li, UCAR European Representative
3:25 - 3:35
Brenmiller Energy, Ltd. (NASDAQ: BNRG)
Keynote speaker: Nir Brenmiller, COO
3:40 – 3:50
Monumental Energy Corp. (OTCQB: MNMRF) (TSXV: MNRG)
Keynote speaker: Maximilian Sali, VP Corporate Development, Founder & Director
3:55 – 4:05
Sky Harbour Group Corporation (NYSE American: SKYH)
Keynote speakers: Tal Keinan, Founder and CEO
4:10 – 4:20
Cyios Corp. (OTC Pink: CYIO)
Keynote speaker: John O’Shea, Chairman
Day 2 - Tomorrow
January 16, 2025
12:00
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.
12:30
Introduction
12:35 – 1:05
Tytonyx, a private company
Keynote speakers: Jim Snow, Director
1:10 - 1:40
Bioxytran, Inc. (OTCQB: BIXT)
Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development
1:45 - 2:15
RUA Gold, Inc. (OTCQB: NZAUF) (CSE: RUA)
Keynote speaker: Robert Eckford, CEO
2:20 – 2:30
Ideal Power, Inc. (NASDAQ: IPWR)
Keynote speakers: Dan Brdar: President and CEO, & Tim Burns: CFO
2:35 – 3:05
GeoVax Labs, Inc. (NASDAQ: GOVX)
Keynote speakers: David Dodd, Chairman, President / CEO
3:10 - 3:20
Vivani Medical, Inc. (NASDAQ: VANI)
Keynote speaker: Adam Mendelsohn PHD, CEO
3:25 - 3:35
BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV)
Keynote speaker: James Passin, CEO
3:40 – 3:50
Viomi Technology Co., Ltd. (NASDAQ: VIOT)
Keynote speakers: Claire Ji – IR & Finance, and Sam Yang, Head of Capital and Strategy
3:55 – 4:05
Eloro Resources, Ltd. (OTCQX: ELRRF) (TSX: ELO)
Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration
4:10 – 4:20
Realbotix Corp. (OTCQB: XBOTF) (TSXV: XBOT)
Keynote speaker: Andrew Kiguel Co-Founder, CEO
Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.
Register for the Conference here.
Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Replays: Subscribe to our YouTube Channel
About EmergingGrowth.com
Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.
About the Emerging Growth Conference
The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.
All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.
If you believe or know of a company that might fit our audience, contact us here.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
Contact:
Emerging Growth
Phone: 1-305-330-1985
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.09 |
Daily Change: | -0.0005 -0.55 |
Daily Volume: | 83,160 |
Market Cap: | US$7.930M |
July 18, 2024 March 06, 2024 February 21, 2024 October 24, 2023 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load